Nvron Health Care Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 09-12-2024
- Paid Up Capital ₹ 5.00 M
as on 09-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 164.63%
(FY 2022)
- Profit -213.72%
(FY 2022)
- Ebitda -266.80%
(FY 2022)
- Net Worth -31.62%
(FY 2022)
- Total Assets -41.59%
(FY 2022)
About Nvron Health Care
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Subash Kumar and Radhajanani Sukumar serve as directors at the Company.
- CIN/LLPIN
U24299TZ2016PTC027712
- Company No.
027712
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nvron Health Care Private Limited offer?
Nvron Health Care Private Limited offers a wide range of products and services, including Physiotherapy & Rehab Aids, Heat Therapy Equipments, Fracture Aid, Thermometers & Flowmeters, Clinical Thermometer, Cosmetics, Hair & Beauty Products, Skin Care Cosmetics, Bathroom Accessories, Soap & Sanitizer Dispenser, Surgical & ICU Equipments.
Who are the key members and board of directors at Nvron Health Care?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subash Kumar  | Director | 27-Jun-2016 | Current |
| Radhajanani Sukumar | Director | 15-Jul-2019 | Current |
Financial Performance of Nvron Health Care.
Nvron Health Care Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 164.63% increase. The company also saw a substantial fall in profitability, with a 213.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 31.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nvron Health Care?
In 2021, Nvron Health Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nvron Life Science LimitedActive 9 years 5 monthsSubash Kumar and Radhajanani Sukumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nvron Health Care?
Unlock and access historical data on people associated with Nvron Health Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nvron Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nvron Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
